[1]
Wilson, P.M., Dixon, S., Vell, T., Bower, P., Rootkin, L., Williams, C., Strong, A., Lawrence, D., Elvey, R., Williams, O., Stein, N. and Gibson, J.M. 2023. Implementation of inclisiran in UK primary care for patients with atherosclerotic cardiovascular disease (ASCVD) or ASCVD-risk equivalents: rationale and design of VICTORION-Spirit, a pragmatic phase IIIb, randomised controlled study. International Journal of Clinical Trials. 10, 2 (Apr. 2023), 156–165. DOI:https://doi.org/10.18203/2349-3259.ijct20231106.